Targeting the issues in chronic obstructive lung disease

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.8, Iss.1, 2003-05, pp. : 83-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic obstructive pulmonary disease: consequences beyond the lung

By Shrikrishna Dinesh Hopkinson Nicholas S

Clinical Medicine, Vol. 12, Iss. 1, 2012-02 ,pp. : 71-74

Royal College Of Physicians

Access to resources Recommend Favorite

Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment

By Barnes Peter J

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1111-1121

Informa Healthcare

Access to resources Recommend Favorite

Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario Ciaprini Chiara Page Clive P Matera Maria G

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 10, 2007-10 ,pp. : 1273-1286

Informa Healthcare

Access to resources Recommend Favorite

Infliximab for chronic obstructive pulmonary disease: towards a more specific inflammation targeting?

By Antoniu Sabina A

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 181-184

Informa Healthcare

Access to resources Recommend Favorite

Chronic Obstructive Pulmonary Disease: An Update on Diagnosis and Management Issues in Older Adults

By Nazir Shoab A. Erbland Marcia L.

Drugs & Aging, Vol. 26, Iss. 10, 2009-10 ,pp. : 813-831

Adis International

Access to resources Recommend Favorite